Answers are grounded in this paper and cite their sources.
Based on co-culture and chimeric tumor models, active Shh-mediated signaling was demonstrated between AI prostate cancer and NPF in a paracrine- and tumor progression-dependent manner. Our study suggests that drugs like cyclopamine that interfere with Shh signaling could be beneficial in preventing AI progression in prostate cancer cells.
No takes yet. Share an insight, caveat, or question.
Shigemura et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: